Predictions
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€18.96
17.04.23
17.04.23
€25.65
17.04.24
17.04.24
-29.79%
18.04.24
18.04.24
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€3.98
17.04.23
17.04.23
€11.91
17.04.24
17.04.24
11.06%
18.04.24
18.04.24
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€1.11
02.04.24
02.04.24
-
02.04.25
02.04.25
-38.74%
16.04.24
16.04.24
Could be very worthwhile Investment >20% year
Pfizer Inc.
Start price
Target price
Perf. (%)
€37.60
15.04.23
15.04.23
€40.00
15.04.24
15.04.24
-34.95%
16.04.24
16.04.24
Could be worthwhile Investment >10% per year
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.88
15.04.24
15.04.24
€3.00
31.10.25
31.10.25
-
15.04.24
15.04.24
Could be very worthwhile Investment >20% year
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.43
24.06.23
24.06.23
€3.00
31.12.25
31.12.25
-43.01%
15.04.24
15.04.24
Could be very worthwhile Investment >20% year
Applied Therapeutics Inc
Start price
Target price
Perf. (%)
€5.80
19.02.24
19.02.24
-
19.02.25
19.02.25
-14.83%
15.04.24
15.04.24
Risky Investment
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.72
11.04.24
11.04.24
-
11.04.25
11.04.25
-12.21%
14.04.24
14.04.24
Could be worthwhile Investment >10% per year
Nektar Therapeutics
Start price
Target price
Perf. (%)
€1.50
11.04.24
11.04.24
-
11.04.25
11.04.25
3.27%
14.04.24
14.04.24
Risky Investment
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€66.50
07.04.24
07.04.24
-
07.04.25
07.04.25
0.75%
14.04.24
14.04.24
Could be very worthwhile Investment >20% year
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€33.50
13.04.23
13.04.23
€59.72
13.04.24
13.04.24
-29.85%
14.04.24
14.04.24
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€1.14
02.04.24
02.04.24
-
02.04.25
02.04.25
-28.14%
13.04.24
13.04.24
Could be worthwhile Investment >10% per year
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€1.60
02.04.24
02.04.24
-
02.04.25
02.04.25
-48.88%
13.04.24
13.04.24
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Alpine Immune Sciences Inc
Start price
Target price
Perf. (%)
€11.50
22.07.23
22.07.23
€15.00
31.08.26
31.08.26
430.43%
12.04.24
12.04.24
Could be very worthwhile Investment >20% year